BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Eric Freund, Kim Rouven Liedtke, Julia van der Linde, Hans-Robert Metelmann, Claus-Dieter Heidecke, Lars-Ivo Partecke, Sander Bekeschus. Physical plasma-treated saline promotes an immunogenic phenotype in CT26 colon cancer cells in vitro and in vivoScientific Reports 2019; 9(1) doi: 10.1038/s41598-018-37169-3
2
Linda Aagaard Rasmussen, Henry Jensen, Line Flytkjær Virgilsen, Alina Zalounina Falborg, Henrik Møller, Peter Vedsted. Healthcare utilisation in general practice and hospitals in the year preceding a diagnosis of cancer recurrence or second primary cancer: a population-based register studyBMC Health Services Research 2019; 19(1) doi: 10.1186/s12913-019-4757-y
3
Eric Freund, Kim-Rouven Liedtke, Lea Miebach, Kristian Wende, Amanda Heidecke, Nagendra Kumar Kaushik, Eun Ha Choi, Lars-Ivo Partecke, Sander Bekeschus. Identification of Two Kinase Inhibitors with Synergistic Toxicity with Low-Dose Hydrogen Peroxide in Colorectal Cancer Cells In vitroCancers 2020; 12(1): 122 doi: 10.3390/cancers12010122
4
Sharlene Gill, Jeffrey A. Meyerhardt, Monica Arun, Christine M. Veenstra. Translating IDEA to Practice and Beyond: Managing Stage II and III Colon CancerAmerican Society of Clinical Oncology Educational Book 2019; (39): 226 doi: 10.1200/EDBK_237443
5
Eric Freund, Kim Rouven Liedtke, Rebecca Gebbe, Amanda Kathleen Heidecke, Lars-Ivo Partecke, Sander Bekeschus. In Vitro Anticancer Efficacy of Six Different Clinically Approved Types of Liquids Exposed to Physical PlasmaIEEE Transactions on Radiation and Plasma Medical Sciences 2019; 3(5): 588 doi: 10.1109/TRPMS.2019.2902015
6
Knut Magne Augestad, Marianne A Merok, Dejan Ignatovic. Tailored Treatment of Colorectal Cancer: Surgical, Molecular, and Genetic ConsiderationsClinical Medicine Insights: Oncology 2017; 11: 117955491769076 doi: 10.1177/1179554917690766
7
Mark Jeffery, Brigid E Hickey, Phil N Hider, Adrienne M See. Follow-up strategies for patients treated for non-metastatic colorectal cancerCochrane Database of Systematic Reviews 2016;  doi: 10.1002/14651858.CD002200.pub3
8
Allison Y. Ye, Winson Y. Cheung, Karen J. Goddard, Daniel Horvat, Robert A. Olson. Follow-up patterns of cancer survivors: a survey of Canadian radiation oncologistsJournal of Cancer Survivorship 2015; 9(3): 388 doi: 10.1007/s11764-014-0390-2
9
Mark Jeffery, Brigid E Hickey, Phillip N Hider. Follow-up strategies for patients treated for non-metastatic colorectal cancerCochrane Database of Systematic Reviews 2019;  doi: 10.1002/14651858.CD002200.pub4
10
Michele M. Gage, Matthew T. Hueman. Colorectal Cancer Surveillance: What Is the Optimal Frequency of Follow-up and Which Tools Best Predict Recurrence?Current Colorectal Cancer Reports 2017; 13(4): 316 doi: 10.1007/s11888-017-0382-5